Sartorius Stedim Biotech SA (DIM) – Company Profile and SWOT Analysis

Sartorius Stedim Biotech SA (DIM) – Company Profile & SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Sartorius Stedim Biotech SA (SSB), a subsidiary of Sartorius AG, is a supplier of equipment and services to biopharmaceutical companies. It offers integrated solutions covering filtration, fermentation, fluid management, purification, and cell cultivation. Its major products include laboratory balances, OEM weigh cells, mass comparators, lab water accessories, pipettes, moisture analyzers, bioreactors, filters, chromatography consumables among others. The company also offers a complete range of services from conceptual design, contract testing & research, and detailed engineering. It services includes bioprocess consulting & engineering, cell culture media services, biologics testing, instrument service, validation service and biologics contract services. The company’s products find application in the production process of medicines in biopharmaceutical and pharmaceutical industries. SSB sells products through direct sales force in the Americas, Europe, the Middle East, Africa, and Asia-Pacific. SSB is headquartered in Aubagne, Provence – Alpes- Cote d'Azur, France.

Scope

• Detailed information on Sartorius Stedim Biotech SA required for business and competitor intelligence needs

• A study of the major internal and external factors affecting Sartorius Stedim Biotech SA in the form of a SWOT analysis

• An in-depth view of the business model of Sartorius Stedim Biotech SA including a breakdown and examination of key business segments

• News about Sartorius Stedim Biotech SA, such as business expansion, restructuring, and contract wins

• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

• Gain understanding of Sartorius Stedim Biotech SA and the factors that influence its strategies.

• Track strategic initiatives of the company and latest corporate news and actions.

• Assess Sartorius Stedim Biotech SA as a prospective partner, vendor or supplier.

• Support sales activities by understanding your customers' businesses better.

• Stay up to date on Sartorius Stedim Biotech SAs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Bio-Rad Laboratories Inc

Merck KGaA

Agilent Technologies Inc

Thermo Fisher Scientific Inc

Danaher Corp

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Sartorius Stedim Biotech SA - Key Facts

Sartorius Stedim Biotech SA - Key Employees

Sartorius Stedim Biotech SA - Key Employee Biographies

Sartorius Stedim Biotech SA - Major Products and Services

Sartorius Stedim Biotech SA - History

Sartorius Stedim Biotech SA - Company Statement

Sartorius Stedim Biotech SA - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 – Company Analysis

Company Overview

Sartorius Stedim Biotech SA - Business Description

Geographical Segment: Americas

Performance

Geographical Segment: Asia Pacific

Performance

Geographical Segment: EMEA

Performance

R&D Overview

Sartorius Stedim Biotech SA - Corporate Strategy

Sartorius Stedim Biotech SA - SWOT Analysis

SWOT Analysis - Overview

Sartorius Stedim Biotech SA - Strengths

Sartorius Stedim Biotech SA - Weaknesses

Sartorius Stedim Biotech SA - Opportunities

Sartorius Stedim Biotech SA - Threats

Sartorius Stedim Biotech SA - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

Sartorius Stedim Biotech SA, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026

Sartorius Stedim Biotech SA, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026

Sartorius Stedim Biotech SA, Recent Deals Summary

Section 5 – Company’s Recent Developments

May 21, 2026: Sartorius Opens Competence Center for Cell and Gene Therapy Components in Freiburg

Apr 23, 2026: Sartorius Stedim Biotech Reports Strong Q1 2026 Results

Mar 24, 2026: Mixed General Meeting Resolutions of Sartorius Stedim Biotech S.A.

Mar 17, 2026: Sartorius Sharpens Strategy With Biopharma Focus, Sets New Mid-Term Growth Targets

Feb 03, 2026: Sartorius Stedim Biotech Achieves Considerable Profitable Growth in 2025 and Maintains Positive Outlook

Jul 29, 2025: Bio Usawa Biotechnology and Sartorius Stedim Biotech Enter Into Partnership

Jul 09, 2025: Sartorius Stedim Biotech and Sensible Biotechnologies Sign Memorandum of Understanding

Jun 17, 2025: Sartorius expands manufacturing and R&D capacities for innovative bioprocess solutions in France

Feb 17, 2025: Sartorius Releases Annual Report Financial Results for 2024 Read Media Release

Section 6 – Appendix

Methodology

Ratio Definitions

About MarketLine

Contact Us

Disclaimer

List of Tables

List of Tables

Sartorius Stedim Biotech SA, Key Facts

Sartorius Stedim Biotech SA, Key Employees

Sartorius Stedim Biotech SA, Key Employee Biographies

Sartorius Stedim Biotech SA, Major Products and Services

Sartorius Stedim Biotech SA, History

Sartorius Stedim Biotech SA, Subsidiaries

Sartorius Stedim Biotech SA, Key Competitors

Sartorius Stedim Biotech SA, Ratios based on current share price

Sartorius Stedim Biotech SA, Annual Ratios

Sartorius Stedim Biotech SA, Annual Ratios (Cont…1)

Sartorius Stedim Biotech SA, Annual Ratios (Cont…2)

Sartorius Stedim Biotech SA, Interim Ratios

Sartorius Stedim Biotech SA, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026

Sartorius Stedim Biotech SA, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026

Sartorius Stedim Biotech SA, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Sartorius Stedim Biotech SA, Performance Chart (2020 – 2024)

Sartorius Stedim Biotech SA, Ratio Charts

Sartorius Stedim Biotech SA, Pharmaceuticals & Healthcare, Deals By Year, 2019 to YTD 2025

Sartorius Stedim Biotech SA, Pharmaceuticals & Healthcare, Deals by Type, 2019 to YTD 2025

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports